A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, ...
A British trial showing that a common steroid could reduce deaths in severe COVID-19 cases by one-third was good news for Minnesota physicians who have been battling the infectious disease without a ...
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024. Please provide your key takeaways from this study.How might these findings impact the management of ...
A potential COVID-19 treatment is delivering promising results in clinical trials, with dexamethasone helping cut deaths in cases of severe respiratory complications. The potential of the drug, a ...
Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial The trial enrolled 31 ...
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial CASTOR was a multicenter, randomized, open ...
A dexamethasone-sparing regimen of daratumumab and lenalidomide was safe and effective in older, frail patients with newly diagnosed multiple myeloma. Among that select group of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results